Please Wait.....
Report
Gastrointestinal OTC Drugs Market by Drug Class (Laxatives, Gastrointestinal Cancer Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2 Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics), Indication (Gastroesophageal Reflux Disease (GERD) or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032
Market Report I 2024-07-01 I 145 Pages I IMARC Group
The global gastrointestinal OTC drugs market size reached US$ 42.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 60.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.
Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.
Gastrointestinal OTC Drugs Market Trends:
The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global gastrointestinal OTC drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on drug class, indication, and end user.
Drug Class Insights:
Laxatives
Gastrointestinal Cancer Treatments
Gastric Acid Reducers
Anti-Diarrheal
Proton Pump Inhibitors
H2 Inhibitors
Gastric Acid Neutralizers
Bowel Anti-Inflammatory
Anti-Emetics
The report has provided a detailed breakup and analysis of the gastrointestinal OTC drugs market based on the drug class. This includes laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti-diarrheal, proton pump inhibitors, H2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory, and anti-emetics.
Indication Insights:
Gastroesophageal Reflux Disease (GERD) or Heartburn
Constipation
Diarrhea
Motion Sickness
Others
A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the indication has also been provided in the report. This includes gastroesophageal reflux disease (GERD) or heartburn, constipation, diarrhea, motion sickness, and others.
End User Insights:
Hospitals
Clinics
Others
A detailed breakup and analysis of the gastrointestinal OTC drugs market based on the end user has also been provided in the report. This includes hospitals, clinics, and others.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. How big is the global gastrointestinal OTC drugs market?
2. What is the expected growth rate of the global gastrointestinal OTC drugs market during 2024-2032?
3. What are the key factors driving the global gastrointestinal OTC drugs market?
4. What has been the impact of COVID-19 on the global gastrointestinal OTC drugs market?
5. What are the key regions in the global gastrointestinal OTC drugs market?
6. Who are the key players/companies in the global gastrointestinal OTC drugs market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gastrointestinal OTC Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Laxatives
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Gastrointestinal Cancer Treatments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Gastric Acid Reducers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Anti-Diarrheal
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Proton Pump Inhibitors
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 H2 Inhibitors
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Gastric Acid Neutralizers
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Bowel Anti-Inflammatory
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Anti-Emetics
6.9.1 Market Trends
6.9.2 Market Forecast
7 Market Breakup by Indication
7.1 Gastroesophageal Reflux Disease (GERD) or Heartburn
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Constipation
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diarrhea
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Motion Sickness
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Boehringer Ingelheim GmbH
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.2 Johnson & Johnson
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Prestige Consumer Healthcare Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Purdue Pharma L.P
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Sanofi
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Zydus Lifesciences Limited
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2023
Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2023
Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2023
Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis
Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security